Graham K. Cooper, CFO and Treasurer at Orexigen Therapeutics, Inc. (OREX), sold 8,259 shares at $12.00 ($99K) on 2008-08-21, disclosed to the SEC on 2008-08-25.
Scheduled sale ($99k) by CFO and Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RCPT | SELL | 2014-09-17 | $3.1M | — | Filing → |
| OREX | SELL | 2009-12-23 | $147K | — | Filing → |
| OREX | SELL | 2009-12-23 | $678K | — | Filing → |